Mapping of the familial infantile myasthenia (congenital myasthenic syndrome type Ia) gene to chromosome 17p with evidence of genetic homogeneity


Christodoulou K., Tsingis M., Deymeer F., Serdaroglu P., Ozdemir C., AlShehab A., ...Daha Fazla

HUMAN MOLECULAR GENETICS, cilt.6, sa.4, ss.635-640, 1997 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 6 Sayı: 4
  • Basım Tarihi: 1997
  • Doi Numarası: 10.1093/hmg/6.4.635
  • Dergi Adı: HUMAN MOLECULAR GENETICS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.635-640
  • İstanbul Üniversitesi Adresli: Hayır

Özet

Familial infantile myasthenia is an autosomal recessive disorder, recently classified as congenital myasthenic syndrome type la, Onset of symptoms is at birth to early childhood with significant myasthenic weakness and possible respiratory distress, followed later in life by symptoms of mild to moderate myasthenia, Thirty-six patients of 12 families, seven of them consanguineous, were used to map the familial infantile myasthenia gene. A combination of linkage search through the genome, DNA pooling and homozygosity mapping were employed resulting in the localisation of this disease locus to the telomeric region of chromosome 17p. A maximum led score of 9.28 at theta = 0.034 was obtained between the disease locus and marker locus D17S1537, Haplotype analysis showed all families to be consistent with linkage to this region thus providing evidence for genetic homogeneity of familial infantile myasthenia. Multipoint linkage analysis mapped the disease gene in the similar to 4.0 cM interval between marker loci D17S1537 and D17S1298 with a maximum multipoint lod score of 12.07. Haplotype analysis and homozygosity by descent in affected individuals of the consanguineous families revealed results in agreement with the confinement of the familial infantile myasthenia region within the interval between marker loci D17S1537 and D17S1298.